Lifebit and Flatiron Health announce partnership to accelerate cancer data research
Today, 31 May 2023, Lifebit and Flatiron Health are announcing a multi-year strategic partnership to support vital research and enable scientific discoveries to improve and extend lives by learning from the experience of every person with cancer. Implementing Lifebit’s pioneering federated Trusted Research Environment technology will enable approved researchers to safely and securely access high-quality real-world data on cancer patients to enable breakthrough analysis globally.
“The advanced capabilities of Lifebit’s Trusted Research Environment, coupled with our focus to reimagine the infrastructure of cancer care, will enable us to unlock the potential of cancer data to support research into new therapies and help get them to patients more quickly.”
Dr. Arun Sujenthiran, UK Clinical Lead and Senior Medical Director
Flatiron Health has an international presence across the United Kingdom, Germany, US and Japan and works in collaboration with hospitals and health networks to design custom approaches tailored to each country, to transform and unlock the power of real-world data.
Health data generated by hospitals, healthcare providers, research organisations and clinical trials hold the potential to advance research and innovation, improve patient care and accelerate drug development.
The sensitivity of these data requires the utmost security and privacy measures that demonstrate strict compliance with global data use regulations to ensure patient data protection, and build patient confidence and trust in the use of their data for research.
Lifebit’s federated Trusted Research Environment delivers this necessary security and is already in use with major initiatives including Genomics England, the Danish National Genome Center and NIHR Cambridge Biomedical Research Centre. It brings the analysis to where the data resides and enables researchers and clinicians to securely analyse data in situ, and connect disparate datasets without the data being moved or copied. The strict access controls set on the platform will ensure the data are not shared or accessed without approval nor used for any purpose other than approved research.
This new partnership with Lifebit will enable Flatiron and its partners to continue to support trustworthy and secure access to data, deliver research and innovation to develop new treatments for cancer, and improve patient care and outcomes.
“This partnership will continue to help improve treatment, care and quality of life of people with cancer,” said Dr. Arun Sujenthiran, UK Clinical Lead and Senior Medical Director, Flatiron Health. “The advanced capabilities of Lifebit’s Trusted Research Environment, coupled with our focus to reimagine the infrastructure of cancer care, will enable us to unlock the potential of cancer data to support research into new therapies and help get them to patients more quickly.”
“At Lifebit we are proud to announce this important partnership with Flatiron and to demonstrate our commitment to the safe and secure use of data for research, which we know is so important for building trust and confidence amongst patients,” said Dr. Chiara Bacchelli, Precision Medicine and Human Genetics Lead at Lifebit. “It is a privilege to enable researchers to more effectively collaborate across these rich datasets through the Lifebit platform and we are excited about the possible outcomes for cancer research.”
About Lifebit Biotech Ltd
Lifebit is a global leader in genomics and health data software, empowering organisations across the globe to transform how they securely and safely leverage sensitive biomedical data. We are committed to solving the most challenging problems in precision medicine, genomics and healthcare with a mission to create a world where access to biomedical data will never again be an obstacle to curing diseases.
About Flatiron Health
Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group.
Interested in learning more about Lifebit's data solutions?Contact us